Drug-delivering nanoparticles designed to glow when their target cells die can report on the effectiveness of cancer therapies within just a few hours of treatment, a mouse study shows.
A new camera system supports the visualization of gliomas stained with Tumor Paint, a chlorotoxin-based imaging agent that’s currently in clinical trials.